Benzinga - Thu, 08 Apr 2021 16:49:44 -0400
Benzinga - Thu, 08 Apr 2021 13:08:40 -0400
Benzinga - Thu, 08 Apr 2021 08:11:19 -0400
Benzinga - Mon, 29 Mar 2021 08:09:06 -0400
Benzinga - Mon, 29 Mar 2021 07:01:49 -0400
Benzinga - Mon, 29 Mar 2021 05:16:11 -0400
Benzinga - Fri, 26 Mar 2021 17:12:02 -0400
Benzinga - Fri, 26 Mar 2021 12:50:22 -0400
Benzinga - Fri, 26 Mar 2021 12:07:14 -0400
Benzinga - Fri, 26 Mar 2021 10:26:17 -0400
Benzinga - Fri, 26 Mar 2021 09:35:38 -0400
load more
Sector: Health Care.Industry: Biotechnology
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-03
REV
Q4 2020Est.ActualSurprise
EPS
(EXPECTED)2021-04-23
REV

Related Companies

TickerCompanyChg %Mkt Cap
ATNF180 Life Sciences9.56%234.5M

180 Life Sciences Company Questions & Answers

Q

How do I buy 180 Life Sciences (ATNF) stock?

A

You can purchase shares of 180 Life Sciences (NASDAQ: ATNF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are 180 Life Sciences's (ATNF) main competitors?

A

Other companies in 180 Life Sciences’s space includes: T2 Biosystems (NASDAQ:TTOO), Larimar Therapeutics (NASDAQ:LRMR) and Atossa Therapeutics (NASDAQ:ATOS).

Q

What is the target price for 180 Life Sciences?

A

There is no analysis for 180 Life Sciences

Q

How much is 180 Life Sciences (ATNF) stock ?

A

The stock price for 180 Life Sciences (NASDAQ: ATNF) is $9.74 last updated Fri Apr 09 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next 180 Life Sciences (ATNF) dividend?

A

There are no upcoming dividends for 180 Life Sciences.

Q

When is 180 Life Sciences (NASDAQ:ATNF) reporting earnings?

A
180 Life Sciences’s Q1 earnings are confirmed after-market from now on May 3, 2021.
Q

When is the upcoming split for ATNF?

A

There is no upcoming split for 180 Life Sciences.